Covid jabs huge success, but work needed on trust in vaccines – key findings from Covid report/in /by
Immunisation saved hundreds of thousands of UK lives, but vaccine hesitancy remains an issue.
Covid jabs huge success, but work needed on trust in vaccines – key findings from Covid report/in /by
Immunisation saved hundreds of thousands of UK lives, but vaccine hesitancy remains an issue.
Vaccines a huge success, but public trust must be earned – key findings from Covid report/in /by
Immunisation saved hundreds of thousands of UK lives, but vaccine hesitancy remains an issue.
Vaccines a huge success, but public trust must be earned – key findings from Covid report/in /by
Immunisation saved hundreds of thousands of UK lives, but vaccine hesitancy remains an issue.
Vaccines a huge success, but public trust must be earned – key findings from Covid report/in /by
Immunisation saved hundreds of thousands of UK lives, but vaccine hesitancy remains an issue.
What is the UK Covid inquiry and how does it work?/in /by
The fourth report from the inquiry into the pandemic said the vaccine roll-out was an "extraordinary feat".
What is the UK Covid inquiry and how does it work?/in /by
The fourth report from the inquiry into the pandemic said the vaccine roll-out was an "extraordinary feat".
Breakthrough £90,000 Alzheimer’s drugs unlikely to benefit patients, report suggests/in /by
A major review has provoked a backlash after concluding the medicines provide too little benefit to be noticed.
Breakthrough £90,000 Alzheimer’s drugs unlikely to benefit patients, report suggests/in /by
A major review has provoked a backlash after concluding the medicines provide too little benefit to be noticed.
Breakthrough £90,000 Alzheimer’s drugs unlikely to benefit patients, report suggests/in /by
A major review has provoked a backlash after concluding the medicines provide too little benefit to be noticed.